AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

RecruitingPhase 2, Phase 3Ages 18 Years - anyAllMemorial Sloan Kettering Cancer Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study will see whether collecting and analyzing needle biopsy samples from cancer liver metastases after a tumor ablation procedure will be able to identify cancer cells that are still alive. The results of these biopsies could help determine the next treatment for your cancer, but the biopsies could cause side effects.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of liver metastases from various primary tumors * Confined liver disease or limited extrahepatic disease stable/controlled for at least 4 months (extrahepatic disease amenable to treatment is allowed) * Lesions of โ‰ค3 cm in maximum diameter * At least one FDG-avid lesion to be treated\*\*\* * INR \< 1.5\* * Platelet count โ‰ฅ 50,000 Exclusion Criteria: * Age \< 18 * Less than 5 mm distance to a structure (GI or biliary tract), that cannot be protected from ablation injury with technical modifications such as hydro or air dissection * INR \> 1.5 that cannot be corrected with fresh frozen plasma \*\* * Platelet count of \<50,000 that cannot be corrected with transfusion * More than 3 tumors in the liver * More than 5 tumors of extrahepatic disease (including mediastinal nodes and pulmonary nodules, abdominal or other lymph nodes, and bone metastasis) * Presence of any peritoneal Carcinomatosis * For patients on Coumadin, general clinical guidelines for IR ablation will be followed. * For patients with no FDG-PET avid tumors aim 2 of the protocol will not be assessed
๐Ÿ’Š

What it tests

  • [18-F]- FDG - PET
  • Tumor ablation (TA)
  • PET/CT Scan
๐Ÿ“

Where

1 site
Memorial Sloan Kettering Cancer Center
New York, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy